Dr. Scott Pollack – IDO Inhibitors and their Pharmacological Effects
In conjunction with his presentation at the London Excel at ELRIG Drug Discovery 2018, Dr. Scott Pollack, Associate Director of Biophysics and Enzymology at Sygnature Discovery, was asked:
“What are IDO inhibitors and how do you assess their pharmacological effects?”